Shopping Cart 0
Cart Subtotal
USD 0

Pharmaceuticals in Europe

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Pharmaceuticals in Europe

Summary

Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Europe pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The European pharmaceuticals market had total revenues of USD 265.9bn in 2017, representing a compound annual growth rate (CAGR) of 3.4% between 2013 and 2017.

- In many European countries, an aging population and the diseases associated with this have driven growth in the pharmaceutical market.

- Expansion in Europe is limited by increasing focus upon the use of generic drugs by healthcare systems across the region. France, in particular, is placing public stress on capping costs through avoiding branded drugs.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Europe

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Europe pharmaceuticals market by value in 2017?

- What will be the size of the Europe pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Europe pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Europe's pharmaceuticals market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 15

Supplier power 17

New entrants 19

Threat of substitutes 21

Degree of rivalry 22

Leading Companies 24

Johnson & Johnson 24

Novartis AG 27

Pfizer Inc. 30

F. Hoffmann-La Roche Ltd 34

Methodology 37

Industry associations 38

Related MarketLine research 38

Appendix 39

About MarketLine 39


List Of Figure

List of Figures

Figure 1: Europe pharmaceuticals market value: USD billion, 2013-17

Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Europe pharmaceuticals market share: % share, by value, 2017

Figure 4: Europe pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Europe, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Europe, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Europe, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2017

Figure 11: Johnson & Johnson: revenues & profitability

Figure 12: Johnson & Johnson: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Pfizer Inc.: revenues & profitability

Figure 16: Pfizer Inc.: assets & liabilities

Figure 17: F. Hoffmann-La Roche Ltd: revenues & profitability

Figure 18: F. Hoffmann-La Roche Ltd: assets & liabilities


List Of Table

List of Tables

Table 1: Europe pharmaceuticals market value: USD billion, 2013-17

Table 2: Europe pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Europe pharmaceuticals market share: % share, by value, 2017

Table 4: Europe pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Johnson & Johnson: key facts

Table 6: Johnson & Johnson: key financials (USD )

Table 7: Johnson & Johnson: key financial ratios

Table 8: Novartis AG: key facts

Table 9: Novartis AG: key financials (USD )

Table 10: Novartis AG: key financial ratios

Table 11: Pfizer Inc.: key facts

Table 12: Pfizer Inc.: key financials (USD )

Table 13: Pfizer Inc.: key financial ratios

Table 14: F. Hoffmann-La Roche Ltd: key facts

Table 15: F. Hoffmann-La Roche Ltd: key financials (USD )

Table 16: F. Hoffmann-La Roche Ltd: key financials (CHF)

Table 17: F. Hoffmann-La Roche Ltd: key financial ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com